Finding the right tests…
Emergency services available 24 x 7
Finding the right tests…
Molecular
TB culture for AFB grows Mycobacterium tuberculosis directly from a sample, usually sputum, in the lab rather than just detecting its genetic material or staining for it under a microscope. It remains the reference-standard test for confirming active TB disease, because a positive culture is definitive proof of live, growing bacteria, and only a culture-based test can tell your doctor which antibiotics will actually work against your specific infection through drug susceptibility testing. Doctors usually collect at least three sputum samples on different occasions, including one first thing in the morning, since a single sample can miss TB that a repeat sample catches. The lab grows the sample on solid media, in liquid media, or both.
A positive culture confirms active TB disease and lets the lab run drug susceptibility testing on the actual organism recovered, which is more reliable than testing done straight from a raw sample. A negative culture across all samples collected makes active TB less likely but, especially with a single specimen, doesn't fully rule it out, particularly in extrapulmonary or low-bacteria disease. Because M. tuberculosis grows far more slowly than ordinary bacteria, doctors often start treatment based on symptoms, imaging, and a faster test like direct microscopy or PCR while culture is still pending, and adjust later if the culture result changes the picture.
Newer molecular tests like PCR detect fragments of TB DNA, which can come from bacteria that are dead or alive and doesn't always mean active infection. Culture only grows if live, replicating bacteria are present, which is why a positive culture remains the most definitive confirmation of active TB disease, and why molecular tests do not replace it.
A single sputum sample can miss TB that's genuinely present, since bacteria counts vary between collections. Standard practice collects at least three sputum specimens, spaced roughly 8 to 24 hours apart, with at least one taken early in the morning when bacterial counts tend to be highest.
Labs can grow TB culture on solid media, a gel-like surface, or in liquid media, and current practice favors liquid culture as the primary method. A large comparison found solid culture alone caught a small share of cases liquid culture missed, but for respiratory specimens, running both added little beyond liquid culture alone, which is why many labs use liquid culture as the main method and add solid culture selectively.
Beyond confirming diagnosis, a grown culture lets the lab test the bacteria against a panel of TB drugs to see which ones will work, something a DNA-based test alone can't offer. It also allows genotyping to trace how TB spreads between people.
PCR detects fragments of TB DNA, which can come from bacteria that are dead or alive and doesn't always confirm active infection on its own. Culture only grows if live, replicating bacteria are present, which is why it remains the more definitive confirmation of active TB disease.
A single sample can miss TB that's genuinely present, since the number of bacteria coughed up varies between collections. Standard practice collects at least three samples, including one taken early in the morning when bacterial counts tend to be highest.
Mycobacterium tuberculosis grows far more slowly than ordinary bacteria, so the lab needs to give it time to multiply to detectable levels before a result can be read. Ask your doctor or the centre about timing for your specific case.
This page is general information about the test, not medical advice. Your own report's reference ranges apply — please discuss your results with your doctor.
Solid culture grows TB on a gel-like surface, while liquid culture uses a broth-based system that's now the more commonly used primary method. Labs sometimes run both, since each occasionally catches a case the other misses, though the added benefit of running both varies by specimen type.
Yes. Once bacteria grow in culture, the lab can test them directly against a panel of TB drugs to see which ones are effective, something a DNA-based test alone can't offer with the same certainty.
A negative culture across all samples collected makes active TB less likely but doesn't fully rule it out, particularly with a single specimen or in extrapulmonary disease. Your doctor weighs it alongside symptoms, imaging, and other test results.